Its unique mechanism of action complements existing treatments, providing an additional avenue for managing hypertension
Last reviewed: June 12, 2026 Last updated: June 12, 2026 Written by: Jay Hastings, CEO of PlexusDx Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations
At the moment, only two RCD modalities with clearly described and distinct molecularly defined pathways have been reported for mature erythrocytes, termed eryptosis and erythronecroptosis: counterparts of apoptosis and necroptosis (Fig
Tests carried out with GLP-1 had so far proved disappointing, leading many to question its role in glucose metabolism
Looking back, I dont see Rybelsus as the thing that "fixed" me, but as something that finally gave me a fighting chance to take charge again